Results
21,632 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 35 | Nueno CarlosPresident, International |  TDOCTeladoc Health, Inc.Open-market sale | SELL | $29K 3,897 sh | Dec 3, 2025 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 35 | Nueno CarlosPresident, International | TDOCTeladoc Health, Inc. Open-market sale | SELL | $29K 3,897 sh | Dec 3, 2025 |
| 34 | Small MartinCFO & Senior Managing Director |  BLKBlackRock, Inc.Open-market sale | SELL | $1.31M 1,258 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 32 | Voskanian ShauntChief Revenue Officer |  FIGFigma, Inc.Open-market sale | SELL | $215K 6,076 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 31 | Ingram VanSVP, CHF DEVELOPMENT OFFICER |  JACKJACK IN THE BOX INCOpen-market sale | SELL | $2,805 147 sh | Dec 3, 2025 traded Dec 3, 2025 |
| 31 | Allan JonathanGENERAL COUNSEL & CORP SEC |  STOKStoke Therapeutics, Inc.Open-market sale | SELL | $26K 868 sh | Dec 3, 2025 traded Dec 2, 2025 |
| 31 | Ingram VanSVP, CHF DEVELOPMENT OFFICER | JACKJACK IN THE BOX INC Open-market sale | SELL | $3,893 204 sh | Dec 3, 2025 traded Dec 3, 2025 |
| 31 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $43K 1,394 sh | Dec 3, 2025 traded Dec 3, 2025 |
| 30 | Berkley Neil LindsayChief Bus Ofcr & Interim CFO |  ALECAlector, Inc.Open-market sale | SELL | $42K 37.3K sh | Dec 3, 2025 traded Dec 3, 2025 |
| 30 | Wong-Sarad GracePrincipal Accounting Officer | ALECAlector, Inc. Open-market sale | SELL | $9,019 8,056 sh | Dec 3, 2025 traded Dec 3, 2025 |
| 29 | Kleinerman ChristianEVP, Product Management |  SNOWSnowflake Inc.Open-market sale · 10b5-1 plan | SELL | $2.50M 10.0K sh | Dec 3, 2025 traded Dec 1, 2025 |
| 27 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $27K 898 sh | Dec 3, 2025 traded Dec 3, 2025 |
| 23 | Sylebra Capital LlcSee Footnote |  PIIMPINJ INCOpen-market sale | SELL | $7.04M 41.9K sh | Dec 3, 2025 traded Dec 2, 2025 |
| 23 | Rodrigues Fernando M.President of BetterHelp | TDOCTeladoc Health, Inc. Open-market sale · 10b5-1 plan | SELL | $31K 4,209 sh | Dec 3, 2025 traded Dec 3, 2025 |
| 23 | Rodrigues Fernando M.President of BetterHelp | TDOCTeladoc Health, Inc. Open-market sale · 10b5-1 plan | SELL | $17K 2,324 sh | Dec 3, 2025 traded Dec 2, 2025 |
| 23 | Sylebra Capital LlcSee Footnote | PIIMPINJ INC Open-market sale | SELL | $5.19M 31.1K sh | Dec 3, 2025 traded Dec 1, 2025 |
| 23 | Ahamad SamsheerSee Remarks |  SITMSITIME CorpOpen-market sale · 10b5-1 plan | SELL | $1.16M 4,000 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 23 | Banks Matthew C.VP, CAO |  ROKUROKU, INCOpen-market sale · 10b5-1 plan | SELL | $70K 731 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 21 | Sachdeva PrernaChief Accounting Officer |  ALKTALKAMI TECHNOLOGY, INC.Open-market sale | SELL | $22K 1,101 sh | Dec 3, 2025 traded Dec 2, 2025 |
| 21 | Lim Zi YaoGeneral Counsel |  KLICKULICKE & SOFFA INDUSTRIES INCOpen-market sale | SELL | $45K 1,000 sh | Dec 3, 2025 traded Dec 2, 2025 |
| 21 | Still AshleyDirector |  DASHDoorDash, Inc.Open-market sale · 10b5-1 plan | SELL | $13K 62 sh | Dec 3, 2025 traded Dec 2, 2025 |
| 21 | Gil Alexis IIChief Accounting Officer |  IASINTEGRAL AD SCIENCE HOLDING CORP.Open-market sale | SELL | $29K 2,781 sh | Dec 3, 2025 traded Dec 2, 2025 |
| 20 | Kerdman AlinaSVP, Controller & CAO |  CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORPOpen-market sale · 10b5-1 plan | SELL | $12K 151 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 19 | Fukushima RyanChief Operating Officer |  TEMTempus AI, Inc.Open-market sale · 10b5-1 plan | SELL | $67K 904 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 19 | Sivaram RohanCHIEF FINANCIAL OFFICER |  CFLTConfluent, Inc.Open-market sale · 10b5-1 plan | SELL | $177K 8,000 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 19 | Fukushima RyanChief Operating Officer | TEMTempus AI, Inc. Open-market sale · 10b5-1 plan | SELL | $161K 2,128 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 19 | Fukushima RyanChief Operating Officer | TEMTempus AI, Inc. Open-market sale · 10b5-1 plan | SELL | $150K 1,968 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 16 | Schubach Sarah ElizabethChief Accounting Officer |  DBXDROPBOX, INC.Open-market sale · 10b5-1 plan | SELL | $35K 1,168 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS |  NTRANatera, Inc.Open-market sale · 10b5-1 plan | SELL | $364K 1,527 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 16 | Hennessy Daniel JDirector |  INVInnventure, Inc.Open-market sale · 10b5-1 plan | SELL | $421K 82.0K sh | Dec 3, 2025 traded Dec 1, 2025 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $59K 250 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $178K 749 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $114K 474 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 10 | Roth James MChief Revenue Officer |  GTMZoomInfo Technologies Inc.Open-market sale · 10b5-1 plan | SELL | $3,472 343 sh | Dec 3, 2025 traded Dec 2, 2025 |
| 10 | McGrane AshleyGeneral Counsel and Corp Sec | GTMZoomInfo Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $4,194 428 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 6 | McGrane AshleyGeneral Counsel and Corp Sec | GTMZoomInfo Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $729 72 sh | Dec 3, 2025 traded Dec 2, 2025 |
| 6 | Kozarich John WDirector |  LGNDLIGAND PHARMACEUTICALS INCOpen-market sale · 10b5-1 plan | SELL | $18K 92 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 6 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $4,582 23 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 6 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $785 4 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 6 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $18K 92 sh | Dec 3, 2025 traded Dec 1, 2025 |
| 6 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $6,000 30 sh | Dec 3, 2025 traded Dec 1, 2025 |